Related Experiment Video
Updated: Jun 26, 2026
08:46
Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
Published on: May 24, 2012
Lentiviral vector gene transfer into human T cells.
Els Verhoeyen1, Caroline Costa, Francois-Loic Cosset
1Ecole Normale Superior Lyon, Lyon, France.
Methods in Molecular Biology (Clifton, N.J.)
|December 27, 2008
Summary
Efficient gene transfer into T cells is crucial for treating genetic disorders and diseases like AIDS and cancer. Using survival cytokines like IL-7 preserves T cell function and naive cell populations for better gene therapy outcomes.
Area of Science:
- * Molecular biology and immunology.
- * Gene therapy and virology.
Background:
- * Efficient gene transfer into T lymphocytes is essential for treating genetic disorders (e.g., severe combined immunodeficiency) and acquired diseases (e.g., AIDS), as well as cancers.
- * Lentiviral vectors are effective for gene transfer but typically require T cell activation, which can alter T cell phenotype and skew populations, particularly impacting the desired naive T cells crucial for long-term immune reconstitution.
Purpose of the Study:
- * To investigate methods for efficient lentiviral gene transfer into T cells while preserving their functional repertoire and naive phenotype.
- * To detail protocols for T cell transduction using T-cell receptor (TCR) stimulation or recombinant IL-7 (rIL-7) prestimulation.
- * To introduce novel lentiviral vectors engineered with T-cell-activating ligands for targeted gene delivery.
Main Methods:
- * Comparison of lentiviral vector transduction efficiency in T cells using T-cell receptor (TCR) stimulation versus IL-7 prestimulation.
- * Analysis of T cell phenotype (naive vs. memory) post-transduction with different prestimulation methods.
- * Development and application of a new generation of lentiviral vectors displaying T-cell-activating ligands.
Main Results:
- * Prestimulation with survival cytokines IL-2 or IL-7 enables efficient lentiviral gene transfer into T cells.
- * IL-7 prestimulation preserves a functional T-cell repertoire, maintaining an appropriate balance of naive and memory T cells.
- * Novel lentiviral vectors with surface-displayed T-cell-activating ligands facilitate targeted gene transfer.
Conclusions:
- * IL-7 prestimulation offers an improved strategy for lentiviral gene transfer in T cells, preserving naive cell populations essential for effective gene therapy.
- * Targeted gene delivery using engineered lentiviral vectors represents a promising advancement in T-cell-based therapies.
- * These optimized methods enhance the potential for treating hematopoietic system disorders, cancers, and infectious diseases like AIDS via T-cell gene therapy.
